Literature DB >> 30397900

Incidence and predictors of venous thromboembolism in medically ill hospitalized elderly cancer patients: a prospective observational study.

Jeong-Ok Lee1, Ji Yun Lee1, Eun Ju Chun2, Sang Il Choi2, Jin Won Kim1, Se Hyun Kim1, Yu Jung Kim1, Keun-Wook Lee1, Jee Hyun Kim1, Jong Seok Lee1, Soo-Mee Bang3.   

Abstract

PURPOSE: The aim of this study was to estimate the incidence and predictors of venous thromboembolism (VTE) in medically ill hospitalized elderly cancer patients in a single Korean tertiary hospital.
METHODS: Patients were examined for deep vein thrombosis (DVT) by duplex and color Doppler ultrasonography (DUS) of both legs between days 5 and 14 of their hospital stays. The primary endpoint was the incidence of VTE by day 14, which was determined via a composite of DVT detected by routine DUS and symptomatic VTE.
RESULTS: A total of 140 patients with 31 hematologic and 109 nonhematologic malignancies were analyzed. The median age was 73 years, and 45.7% of the patients were female. The median length of hospital stay was 12 days. The modified Padua prediction score (PPS) ≥ 4 was 92.9%. The incidence of VTE by day 14 was 7.1%, including six proximal and four distal DVT cases. Being female, having a length of hospital stay of ≥ 13 days, and having a modified Padua prediction score of ≥ 6 were risk factors of VTE in univariate analysis. The incidence of VTE was 2.3%, 7.3%, and 41.7% in patients with 0-1, 2, and 3 of these risk factors, respectively.
CONCLUSION: The incidence of VTE in medically ill hospitalized elderly cancer patients was lower in Korean patients than in Western patients. However, the risk of VTE in those with more than two risk factors (female, long length of hospitalization, and high PPS) increased considerably, and pharmacologic thromboprophylaxis is warranted in these cases.

Entities:  

Keywords:  Cancer; Elderly; Hospitalized; Risk factors; Venous thromboembolism

Mesh:

Year:  2018        PMID: 30397900     DOI: 10.1007/s00520-018-4537-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  4 in total

1.  Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study.

Authors:  Hirotsugu Kenmotsu; Akifumi Notsu; Keita Mori; Shota Omori; Takahiro Tsushima; Yasuomi Satake; Yoshihiro Miki; Masakazu Abe; Masahito Ogiku; Toshio Nakamura; Masakazu Takagi; Hideto Ochiai; Hirofumi Yasui; Toshiaki Takahashi
Journal:  Cancer Med       Date:  2021-01-09       Impact factor: 4.452

2.  Epidemiology of Cancer-Associated Thrombosis in Asia: A Systematic Review.

Authors:  Lai Heng Lee; Chandramouli Nagarajan; Chuen Wen Tan; Heng Joo Ng
Journal:  Front Cardiovasc Med       Date:  2021-05-21

3.  Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study.

Authors:  Minsu Kang; Koung Jin Suh; Ji-Won Kim; Ja Min Byun; Jin Won Kim; Ji Yun Lee; Jeong-Ok Lee; Soo-Mee Bang; Yu Jung Kim; Se Hyun Kim; Jee Hyun Kim; Jong Seok Lee; Keun-Wook Lee
Journal:  PLoS One       Date:  2022-01-18       Impact factor: 3.240

4.  Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia.

Authors:  Osheiza Abdulmalik; Noureldien H E Darwish; Vandhana Muralidharan-Chari; Maii Abu Taleb; Shaker A Mousa
Journal:  Haematologica       Date:  2022-02-01       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.